References
- Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol 2009;14:350–60.
- King EB, Salt AN, Kel GE, Eastwood HT, O’Leary SJ. Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs. Hear Res 2013;304:159–66.
- Edsman K, Hagerstrom H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005;57:3–22.
- Carlfors J, Edsman K, Petersson R, Jornving K. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 1998;6:113–19.
- Almdal K, Dyre J, Hvidt S, Kramer O. Towards a phenomenological definition of the term ’gel’. Polym Gels Netw 1993;1:5–17.
- Laurent C, Hellstrom S, Appelgren LE, Sehlin J, Lilja K. Fate of exogenous hyaluronic acid in the middle ear. Am J Otolaryngol 1986;7:334–40.
- Wade A, Weller PJ. Handbook of pharmaceutical excipients. In Wade A, Weller PJ, editors. Washington & London: American Pharmaceutical Association and The Pharmaceutical Press; 1994.
- Lapcik LJr, Lapcik L, De Smedt S, Demeester J, Chabrecek P. Hyaluronan: Preparation, Structure, Properties, and Applications. Chem Rev 1998;98:2663–84.
- Bastow ER, Byers S, Golub SB, Clarkin CE, Pitsillides AA, Fosang AJ. Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol Life Sci 2008;65:395–413.
- Ross-Murphy SB, McEvoy H. Fundamentals of hydrogels and gelation. Br Polym J 1986;18:2–7.
- Saber A, Laurell G, Bramer T, Edsman K, Engmér C, Ulfendahl M. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model. Ear Hear 2009;30:81–9.
- Piu F, Wang X, Fernandez R, Dellamary L, Harrop A, Ye Q, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol 2011;32:171–9.
- Bagger-Sjoback D. Sodium hyaluronate application to the open inner ear: an ultrastructural investigation. Am J Otol 1991;12:35–9.
- Laurent C, Anniko M, Hellstrom S. Hyaluronan applied to lesioned round window membrane is free from cochlear ototoxicity. Acta Otolaryngol 1991;111:506–14.
- Gouveris H, Selivanova O, Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 2005;262:131–4.
- Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere’s-associated sudden sensorineural hearing loss. Otol Neurotol 2005;26:890–5.
- Bothner Wik H. Rheological studies of sodium hyaluronate in pharmaceutical preparations [Doctoral thesis]. Uppsala: Uppsala University; 1991.
- Antonelli PJ, Sampson EM, Lang DM. Safety and efficacy of carbomethylcellulose foam in guinea pig middle ear surgery. Otolaryngol Head Neck Surg 2010;142:405–8.
- Wang X, Dellamary L, Fernandez R, Harrop A, Keithley EM, Harris JP, et al. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol 2009;14:393–401.
- Berglin CE, Pierre PV, Bramer T, Edsman K, Ehrsson H, Eksborg S, et al. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. Cancer Chemother Pharmacol 2011;68:1547–56.